GPR110 overexpression increases tumorigenic potential of HER2+breast cancer cells

被引：1
|
作者：
Trivedi, M. V.
Bhat, R.
Yadav, V.
Yadav, P.
Ai-Rawi, A.
Christiny, P.
Nanda, S.
Giuliano, M.
Creighton, C.
Osborne, C. K.
Narkar, V. A.
Schiff, R.
机构：
[1] Univ Houston, Coll Pharm, Houston, TX 77030 USA
[2] Baylor Coll Med, Lester & Sue Smith Breast Ctr, Dan L Duncan Canc Ctr, Houston, TX 77030 USA
[3] Baylor Coll Med, Houston, TX 77030 USA
[4] Univ Texas Houston, Inst Mol Med, Ctr Metab & Degenerat Dis, Houston, TX USA
来源：
CANCER RESEARCH | 2013年 / 73卷
关键词：
D O I：
10.1158/0008-5472.SABCS13-P6-04-05
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P6-04-05
引用
收藏
页数：2
相关论文
共 50 条
  • [1] GPCRs profiling and identification of GPR110 as a potential new target in HER2+breast cancer
    Bhat, Raksha R.
    Yadav, Puja
    Sahay, Debashish
    Bhargava, Dharmendra K.
    Creighton, Chad J.
    Yazdanfard, Sahar
    Al-rawi, Ahmed
    Yadav, Vikas
    Qin, Lanfang
    Nanda, Sarmistha
    Sethunath, Vidyalakshmi
    Fu, Xiaoyong
    De Angelis, Carmine
    Narkar, Vihang A.
    Osborne, C. Kent
    Schiff, Rachel
    Trivedi, Meghana V.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2018, 170 (02) : 279 - 292
  • [2] Role of GPR110 on tumorigenesis and metastasis in HER2+breast cancer in the context of anti-HER2 drug resistance
    Sahay, Debashish
    Bhat, Raksha
    Rimawi, Motthafar
    Osborne, C. Kent
    Schiff, Rachel
    Trivedi, Meghana V.
    [J]. CANCER RESEARCH, 2016, 76
  • [3] The role of GPR110 in tumorigenicity, tumor cell dissemination, and cell cycle regulation in HER2+breast cancer
    Bhat, Raksha
    Qin, Lanfang
    De Angelis, Carmine
    Vasaikar, Suhas
    Thangavel, Hariprasad
    AbdulKareem, Noor
    Zhang, Bing
    Schiff, Rachel
    Trivedi, Meghana V.
    [J]. CANCER RESEARCH, 2019, 79 (13)
  • [4] GPCRs profiling and identification of GPR110 as a potential new target in HER2+ breast cancer
    Raksha R. Bhat
    Puja Yadav
    Debashish Sahay
    Dharmendra K. Bhargava
    Chad J. Creighton
    Sahar Yazdanfard
    Ahmed Al-rawi
    Vikas Yadav
    Lanfang Qin
    Sarmistha Nanda
    Vidyalakshmi Sethunath
    Xiaoyong Fu
    Carmine De Angelis
    Vihang A. Narkar
    C. Kent Osborne
    Rachel Schiff
    Meghana V. Trivedi
    [J]. Breast Cancer Research and Treatment, 2018, 170 : 279 - 292
  • [5] Role of GPR110 in breast cancer
    Bhat, R.
    Qin, L.
    De Angelis, C.
    Sahay, D.
    Bhargava, D.
    Creighton, C.
    Yadav, P.
    Yazdanfard, S.
    Alrawi, A.
    Yadav, V.
    Vasaikar, S.
    Nanda, S.
    Sethunath, V.
    Fu, X.
    Zhang, B.
    Narkar, V.
    Schiff, R.
    Trivedi, M.
    [J]. CANCER RESEARCH, 2019, 79 (04)
  • [6] PPARγ loss increases the metastatic potential of HER2+breast cancer
    Lightbody, Elizabeth D.
    O'Connell, Kathleen M. J.
    Newton, Hailey T.
    Rubino, Rachel R.
    Apostoli, Anthony J.
    Ren, Kevin
    SenGupta, Sandip K.
    Nicol, Christopher J.
    [J]. CANCER RESEARCH, 2018, 78 (13)
  • [7] HER2+breast cancer
    Hicks, David G.
    Kulkarni, Swati
    [J]. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2008, 129 (02) : 263 - 273
  • [8] GPR110 promotes progression and metastasis of triple-negative breast cancer
    Hye-Jung Nam
    Yeon-Ju Kim
    Jae-Hyeok Kang
    Su-Jae Lee
    [J]. Cell Death Discovery, 8
  • [9] Genomics of HER2+breast cancer
    Perou, C.
    [J]. CANCER RESEARCH, 2022, 82 (04)
  • [10] Her-2 overexpression increases the metastatic outgrowth of breast cancer cells in the brain
    Palmieri, Diane
    Bronder, Julie L.
    Herring, Jeanne M.
    Yoneda, Toshiyuki
    Weil, Robert J.
    Stark, Andreas M.
    Kurek, Raffael
    Vega-Valle, Eleazar
    Feigenbaum, Lionel
    Halverson, Douglas
    Vortmeyer, Alexander O.
    Steinberg, Seth M.
    Aldape, Kenneth
    Steeg, Patricia S.
    [J]. CANCER RESEARCH, 2007, 67 (09) : 4190 - 4198
12345